• N&PD Moderators: Skorpio

Does 5-HT2B activation add delirium to 5-HT2A psychedelia?

Wandering Girl

Bluelighter
Joined
Oct 21, 2013
Messages
82
Location
Earth
Before I start, this is not a thread to come in and talk about the dangers of 5-HT2B activation. For all intents and purposes here I am talking about the effects of acute administration, not chronic. Furthermore, I am relating it most significantly to drugs that are known to not have problems because of this. Some more questionable ones will be mentioned as well, but that's not why they are being talked about and I don't think it really applies much here.

So on to the point.... I am a strong proponent of the idea that most receptors in the brain can have a significant impact on the hallucinogenic effects caused by 5-HT2A agonists, even if those receptors didn't seem to be significantly hallucinogenic on their own. Because of this I am always trying to look more into other monoamine receptors specifically so that I can make an attempt to understand the effects of various psychedelics. Following in line with this, one of my biggest interests has been the 5-HT2B receptor.

When I use the term delirium in the title of this thread, I am trying to relate it specifically to the effects caused by anticholinergic deliriants. Not many of the physical effects such as stimulation and dysphoria so much, but the effects on consciousness and perception. In my more reckless days, I experimented with diphenhydramine on occasion.... For those who aren't familiar with the general progression of deliriant hallucinations as doses increase, I will detail my personal experiences and information that I've gathered from the accounts of others here. A lot of people say that deliriants don't have visuals like psychedelics, but I tend to find that the people who say this are the ones who only ever had one strong deliriant trip and never tried them again, and I feel that I can explain this. In lower doses, they definitely do have some more "typical" visual effects; patterning, distortion, and more abstract hallucinations are common. At higher doses, the strength of these effects increases to the point where they cover a much more significant area of your visual perception, reaching fully panoramic scenes at very high doses. I personally believe that that's why those who have only experienced high doses don't believe that normal visuals are common, because they spend their entire trips fully immersed in these strongly-generated imitations of reality rather than riding the line in between "clearheadedness" (I use the term lightly) and full delirium. An example of this with diphenhydramine would be how at full doses people talk about seeing spiders and having full conversations with people. At only moderate doses, I've experienced effects that are quite clearly the same kinds of distortions at work, but to a lesser degree; colorful, translucent form constant patterns with shapes that certainly do resemble the movement of spider legs but don't quite reach that full hallucinations, and hearing random hallucinated words here and there that never amount to full sentences, instead sounding more like sound distortions on something like mushrooms like... which will actually play into what I'm trying to get at in a bit. It's also quite common at least for me on deliriants to stare at certain objects and not realize until looking closer that they're something very different from what I originally thought, but full delirium is not necessarily required for that.

Then there's MDMA. It seems like one in at least every few drug users with much experience is aware of the fact that MDMA can cause a fairly powerful delirium upon either redosing or adding something such as cannabis or ketamine into the mix, particularly on the tail end of the experience. I have also read many reports where people mixed MDMA with full psychedelics, such as one about mescaline that comes to mind especially, and found that the abstract hallucinations of the psychedelic became much more "real" from that point on, generally being pushed into the visionary or out-of-body state. I don't have nearly as much experience with combining MDMA with psychedelics as I would like, but I have redosed and mixed it with cannabis on several occasions to achieve this effect. While the visual effects are slightly differing in their art style in some ways, the overall effects are strikingly similar to what I have experienced on deliriants. The realism of the visuals is out of this world, and it basically feels like a deliriant with some psychedelic flavoring added in. For a long time it was actually a common practice in my group of friends to get this effect going as strongly as possible, and I have friends who managed to trip much harder on it than I did. One in particular stands out who got the furthest of any of us on two separate occasions, and I would say that his behaviors were indistinguishable from someone in the throes of anticholinergic delirium. While the rest of us were mostly achieving the abstract patterning and maybe moments of fleeting full delirium every now and then, he was completely submerged in that panoramic state. The way he responded to use and mumbled to himself and people who weren't there, and kept thinking that we were in his house instead of mine, or thought he was playing Xbox in front of a TV that was off... it was all perfect. I've never even seen someone trip as hard on an actual deliriant as he did on that MDMA and cannabis combination both times, it was like something out of a heavy datura trip report.

I've heard a lot of people suggest that these hallucinogenic effects of MDMA are mediated by its eventual metabolism into MDA, which makes enough sense to me. However, I've also seen research studies that suggest that many of the empathogenic qualities of these drugs (particularly involved in serotonin and dopamine release) come from activation of the 5-HT2B receptor. The same seems to hold true for the more recent research chemical analogues of these drugs as well. I'm going to tie this into a bigger picture, but at first, this is what made me really become interested in it. If we just assume for now that this is the case, that 5-HT2B adds some delirium to the effects of 5-HT2A activation, it would fit quite well, wouldn't it? All of these MDMA analogues that have psychedelic effects are known to cause particularly realistic and delirious hallucinations on top of their normal effects, and though MDMA doesn't on its own because it's lacking in significant 5-HT2A affinity in normal doses, anecdotal reports would seem to suggest that it has the same or at least a similar effect when it is combined with a 5-HT2A agonist. One that especially stands out to me though is MMDA. Reports of this drug are pretty hard to come by, but the most significant one to me is the one here by morninggloryseed. MMDA is said to be a fairly specific serotonin releasing agent, and given its similarity to MDMA I don't think it's absurd to suggest that 5-HT2B plays a role, as well as a 5-HT2A agonist, and it's said to create incredibly realistic visuals with closed eyes. In morninggloryseed's reports, many of the effects he details as part of the experience are extremely similar to those caused by anticholinergic deliriants such as what I mentioned above, and I've even gotten something similar to what he describes about seeing the vivid internet browser with clear but meaningless text on it on diphenhydramine before. I think this is a particularly important example to follow, however you don't have to use something so rare to see this either... many, many people report delirious hallucinations from MDA such as seeing objects or people on the dance floors of clubs that aren't actually there. The more you read about these experiences, I think the harder it gets to differentiate them from many that are reported from anticholinergic deliriants.

Here's what I'm really trying to get at though.... Those MDMA analogues are strong 5-HT2B agonists but presumably not incredibly potent 5-HT2A agonists, as psychedelic effects are not the main part of what they're used for. So what about 5-HT2B activation by something that is used primarily for its psychedelic properties? Well, that leads me here.... Let's consider the four best known psychedelics: LSD, mescaline, psilocin, and DMT. The former two are known for being more stimulating in a dopaminergic way and causing trips that, while they can be very powerful and hallucinogenic, tend to take place more "in reality", even if reality seems pretty difficult to comprehend at the time. The latter two are known for much more easily causing those breakthrough experiences filled with entities that transport you to a completely different realm. LSD has been shown to bind to 5-HT2B only at very high doses, above what would be considered in the normal range of use. As far as I'm aware, mescaline has never been shown to have any significant affinity for 5-HT2B. At least one study I found, on the other hand, has shown psilocin to bind quite strongly to 5-HT2B, maybe even much more so than to 5-HT2A. DMT has been known to bind to 5-HT2B for some time, relatively unselectively in comparison to most other serotonin receptors it binds to. This is quite significant to me, because psilocin has also, in my experience, been the one to cause much more brain fog (not necessarily meant in a bad way), memory disruption, and general dissociation of mind from behaviors than DMT at least at normal doses, which would be supported well by my theory of 5-HT2B delirium if it works as part of a ratio to 5-HT2A effects. The reason all of this is so important though is because those "breakthrough" experiences to me completely resemble the effect of deliriants where abstract hallucinations steadily increasing in realism reach a point of panoramic effect where they overtake your consciousness and bring you to a totally other place. The significant difference here would be that on a deliriant you see things that are, relatively speaking, much more normal, but on a psychedelic the hallucinations would mix with the already very powerful hallucinogenic effects of 5-HT2A activation to create the bizarre dream worlds that users of tryptamines are familiar with.

Many tryptamines, synthetics included, are described as having an empathogenic effect, and it wouldn't surprise me if 5-HT2B activation was the culprit to that too. After all, they're all so similar to serotonin that it really wouldn't be that shocking if most or all of them had some affinity for it.... Tryptamines aren't the only thing that's really making me think this though. Going back to LSD and mescaline... I often see the two related to each other in effect, and both of them to the phenethylamine psychedelics. LSD is of course a bit more tryptamine-y likely due to hitting a few more serotonin receptors, but I generally assumed that dopaminergic effects likely play a role in why these drugs all feel pretty similar to each other. Now I'm thinking though that there's more to it too.... I'd still like to see some affinity data of course, but if mescaline doesn't bind to 5-HT2B then I don't think it would be nuts to expect that many of the 2C-x compounds don't significantly activate it either. If that was the case, wouldn't it make sense to lump then in more with mescaline and LSD? On the other hand, as far as I'm aware many of the DOx compounds have been shown to bind to 5-HT2B, along with bromo-dragonfly and several of the 25x-NBOMe compounds as well. Are those psychedelics not all known for being able to cause particularly powerful hallucinations even leading to possibly psychosis (aka... delirium) at higher doses? The difference would be that they also have significant physical effects, and so you probably wouldn't want to take them at the point of trying to reach breakthrough like you would for a tryptamine; however, I still think the similarities are notable....

I realize that there are no sources in this, but that's just because this is information that I've been building up over time, not something I just worked all on recently. I would be happy to dig up my sources again if anyone needs to see them. I may have left something out too... but if I forgot anything then I'll add it in later in newer posts. In the meantime, does anyone else have anything to add to this, whether it helps or hurts this theory? I'm interested in what anyone has to say!
 
That's an interesting hypothesis, I'm not sure how you'd test it though. Just to clarify, do you think that the 5-HT2B induced delirium involves a cholinergic mechanism, or were you just mentioning anticholinergics for comparison?


One thing you might not realize is that 5-HT2B activity is required for 5-HT releasing agents to exert their effect. In other words blocking 5-HT2B blocks 5-HT release.

That leads me to wonder whether 5-HT2B activity on it's own is enough to drive 5-HT release, and 5-HT2B agonists are therefore causing delirium as a side effect of driving up 5-HT. A sub-hypothesis to add to your hypothesis.
 
I'm glad you think so! I've certainly been interested in it, but yeah, it would be hard to test at least for now. I was really just hoping to maybe get some people thinking about it at the moment, until opportunities like that arise for someone.

I was really just talking about anticholinergics because the effects I've noticed in each of these situations are so similar; even if there isn't a cholinergic method involved, it would not surprise me at all to learn that something happening downstream to each was related. I have been trying to research more about 5-HT2B, but it's been tough to find much.... The main things that stood out to me, aside from what you mentioned, is something about 5-HT2B antagonists exerting an antipsychotic effect by blocking nucleus accumbens dopamine release. However, the 5-HT2B agonist they used in the test failed to have the opposite effect. The other thing was that a study on the interactions between 5-HT2A and mGluR2 when they form heteromers found that mGluR2 will actually form similar links to 5-HT2B; intriguing for sure, but the results of the test also suggested that interactions between 5-HT2A and mGluR2 may not actually be as significant for hallucinations as was once suggested, so hmm....

I have read that thing about 5-HT2B causing serotonin release too, and I think it's very interesting! I'm a fan of your sub-hypothesis, as I was wondering the same thing about it being a possible explanation for the delirium.... Do we know much about how serotonin syndrome causes hallucinations, despite serotonin not being psychedelic? The few accounts of it I've heard actually were more similar to delirium than a psychedelic trip.... I did read something too that said that 5-HT2B is protective against serotonin syndrome. Could it be possible that it's pushing those concentrations beyond what would normally be safe so that that hallucinogenic potential can be explored?
 
Please, no need to 'memberate' in that way--his post was within the scope of the discussion as the de facto topic expanded.
...
I have read that thing about 5-HT2B causing serotonin release too, and I think it's very interesting! I'm a fan of your sub-hypothesis, as I was wondering the same thing about it being a possible explanation for the delirium.... Do we know much about how serotonin syndrome causes hallucinations, despite serotonin not being psychedelic?

An interesting idea. Think of the states toward the end of high-dose entactogen use, eg mistaking people's face, hallucinating nonexistent glasses, etc.

ebola
 
Please, no need to 'memberate' in that way--his post was within the scope of the discussion as the de facto topic expanded.

I apologize, but it wouldn't bug me if it weren't for the fact that I specifically requested to avoid such discussion in the first sentence of my post. The only reason I did so is because I am well aware of the potential physical dangers of chronic 5-HT2B activation and I know that there have already been several other discussions about it, and I wanted what I'm saying here to be taken seriously rather than being dismissed as "It's dangerous, don't do it." Given that there was no other content in his post, it certainly feels as though that's what happened. It's just a little frustrating to me because I'm not even suggesting that anyone take 5-HT2B agonists in any amount to test this, and even warned against high doses of them; I'm just trying to begin a discussion specifically about the receptor's effects in the brain, and I don't think that its effects that only relate to the body are relevant.

An interesting idea. Think of the states toward the end of high-dose entactogen use, eg mistaking people's face, hallucinating nonexistent glasses, etc.

Exactly, this is precisely what I'm getting at. That's just with regular entactogens that it occurs at the end too; those that are also psychedelic like MDA can have them occur as a central part of their hallucinogenic effects. It makes me feel like there's more going on here than we generally assume.
 
I'm on my phone right now so I can't really post these studies I've been reading yet, but I will when I get home. I just found something I think is interesting.... It was pointed out that 5-HT2B acts as a positive autoreceptor in the nucleus accumbens, increasing serotonin release. What I found was a study claiming that serotonin release in the nucleus accumbens increases the release of dopamine and decreases the release of acetylcholine, both of which could certainly lead to psychosis/delirium, but the latter of which would of course especially look good in my comparison to anticholinergics.

However, I also found something stating that MDMA increases acetylcholine levels in the nucleus accumbens at least almost exclusively through an interaction with histamine receptors, particularly H1. Given that many psychedelics interact with histamine receptors as well, the relationship must be considered. I wonder though.... Since 5-HT2B *is* a positive autoreceptor, does that mean that serotonin release there would have sort of a diminishing returns multiplicative effect, whereby with each release a fraction of that serotonin goes toward activating more 5-HT2B over and over again until the concentration becomes too low to stimulate the receptor? And if that's the case, would that imply that a large enough stimulation of 5-HT2B could cause enough iterations to eventually overcome the simply additive effect of H1 agonism? If so, I would also wonder how it relates to so-called more selective serotonin agonists like the DOx and 25x-NBOMe families in the sense that if they lack the histaminergic activity that I believe psilocin and DMT exhibit, could that be part of why their delirium-inducing effects are particularly strong? A higher ratio of acetylcholine lowering to dopamine raising and all that....

Anyway, that's all I've got for now. I'll post those links when I can!
 
Alright, here are those two papers:

Contrasting effects of 5-hydroxytryptamine on the release of dopamine and acetylcholine in the nucleus accumbens of rat.

The interaction between 5-hydroxytryptamine (5-HT) and the release of dopamine and acetylcholine in the nucleus accumbens of rat was investigated. 5-HT (20μM) significantly decreased levels of [3H]-dopamine synthesized from [3H]-tyrosine. 5-HT also enhanced the release of [14C]-dopamine at all concentrations of K+ tested (up to 34 mM). The maximal effect of 5-HT occurred at 15 mM K+ and was reversed by methysergide (3μM). Increasing concentrations of Ca2+ facilitated the releasing effect of 5-HT up to 1.2 mM Ca2+. In contrast, 5-HT had an inhibitory effect on the K+-evoked release of [3H]-acetylcholine synthesized from [3H]-choline. 5-HT was not effective at non-depolarizing concentrations of K+. Increasing the external Ca2+ concentration to 2.5 mM overcame the inhibition of [3H]-acetylcholine release due to 5-HT. These results indicate that 5-HT has at least two actions in the nucleus accumbens, one which is a methysergidesensitive facilitatory action on dopamine release promoted by Ca2+ entry and a second, inhibitory effect on the K+-evoked release of acetylcholine, which is not blocked by methysergide and appears to operate by reducing Ca2+ influx.

MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.

^^ This one has some weird formatting that makes it really frickin' hard for me to copy and paste, so I'm not going to.... Like I said, it's basically just about how it's caused by H1 agonism.

I've been thinking more about this too.... One thing that didn't really occur to me as much before is that, theoretically of course, the more similar a compound is to serotonin the more likely it is to cause this same effect itself, and I suppose that there's a possibility there to overcome some of the histamine agonism too. Or maybe more significantly, perhaps the more serotonergic activity it has in relation to 5-HT2B activation, the more powerfully abstract its hallucinations will be.... For example, MDMA and its analogues would be weak 5-HT2A agonists but strong 5-HT2B agonists and would otherwise more closely mimic phenethylamines than tryptamines, not having nearly as widespread serotonin receptor activation as them (presumably). The end result is that there hallucinations are very realistic, mostly on the delirium end. The next step up would be the DOx and 25x-NBOMe chemicals, which are more powerful psychedelics but otherwise follow the phenethylamine-oriented pattern of receptor affinities. This leads to more hyperspatial visuals, but not quite at the breakthrough level like a tryptamine would be still. Psilocin, the next step up, binds to many serotonin receptors but supposedly does so much more potently still at 5-HT2B than 5-HT2A. This works itself out since the doses taken are typically enough to significantly activate 5-HT2A anyway, and since it is so serotonergic it still has powerful, regular psychedelic hallucinations, but it still doesn't quite compare to DMT, which is said to bind relatively non-selectively to most of its serotonergic targets, the end of result of which would be its very powerful delirium/panoramic dream states combined with potent psychedelic abstract hallucinations synergising to become the breakthrough worlds DMT users know and love. This is all theory still of course, but I think it still fits well....

Anyway, I'll probably still have more to say about this tomorrow, but for now it's time to get some rest.
 
Wandering Girl said:
The reason all of this is so important though is because those "breakthrough" experiences to me completely resemble the effect of deliriants where abstract hallucinations steadily increasing in realism reach a point of panoramic effect where they overtake your consciousness and bring you to a totally other place. The significant difference here would be that on a deliriant you see things that are, relatively speaking, much more normal, but on a psychedelic the hallucinations would mix with the already very powerful hallucinogenic effects of 5-HT2A activation to create the bizarre dream worlds that users of tryptamines are familiar with.

Awesome write-up...I love to see people putting new theories out here like this! I've actually talked with a bluelight pal about this exact same thing. As a pretty extensive user of both deliriants and psychedelics (and combinations of the two), it does seem to me that the breakthrough experiences of substances like dmt or psilocin certainly take on a quality extremely analogous to deliriants. Definitely in their increased realism as you mentioned (complete immersion on the level of all five senses, ability to tangibly interact with the new environment, etc), and also the aspect of entity contact seems highly derivative of the deliriant experience as well (it's pretty much guaranteed in any high-does Nightshade trip I've had). But yeah, as you said, the only major difference would be the preternatural characteristics of the environment/entities due to the added psychological/visual 5-ht2a activation. It pretty much always works out pragmatically as well...I can take psychedelics without these characteristics (like LSD or Mescaline) and add something like Datura or Henbane and they suddenly become "breakthrough"-capable substances, with heavy entity interaction like dmt or psilocin.

Have you had a chance to check out Thomas Ray's work on binding affinities by any chance? http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009019 Although he does list a high binding affinity for Mescaline and the 2-c substances with the 5-ht2b receptor. Interesingly, it also mentions M3, M4, and M5 action with MDMA.

Wandering Girl said:
A lot of people say that deliriants don't have visuals like psychedelics, but I tend to find that the people who say this are the ones who only ever had one strong deliriant trip and never tried them again, and I feel that I can explain this. In lower doses, they definitely do have some more "typical" visual effects; patterning, distortion, and more abstract hallucinations are common.

I know this wasn't the focal point of your original post, but I do think it's really important. This has been my experience as well and I definitely think it deserves more attention. With majority of my low to mid range Nightshade trips there have been definite "psychedelic" characteristics, especially when additional substances are taken to potentiate the visuals of the deliriants. If more people realized this, I think readers would notice a vast increase in the general enjoyability of the TR's on these substances. They're definitely misunderstood to say the least :)

But yeah, fantastic read...some great ideas in there! :)
 
Viṣakaṇṭha;11947191 said:
Awesome write-up...I love to see people putting new theories out here like this! I've actually talked with a bluelight pal about this exact same thing. As a pretty extensive user of both deliriants and psychedelics (and combinations of the two), it does seem to me that the breakthrough experiences of substances like dmt or psilocin certainly take on a quality extremely analogous to deliriants. Definitely in their increased realism as you mentioned (complete immersion on the level of all five senses, ability to tangibly interact with the new environment, etc), and also the aspect of entity contact seems highly derivative of the deliriant experience as well (it's pretty much guaranteed in any high-does Nightshade trip I've had). But yeah, as you said, the only major difference would be the preternatural characteristics of the environment/entities due to the added psychological/visual 5-ht2a activation. It pretty much always works out pragmatically as well...I can take psychedelics without these characteristics (like LSD or Mescaline) and add something like Datura or Henbane and they suddenly become "breakthrough"-capable substances, with heavy entity interaction like dmt or psilocin.

I'm glad you agree! It's nice to see another person experienced with deliriants here, it definitely helps to expand this theory. I'm quite interested in your experience with combinations of psychedelics and deliriants, actually. Were you only using small doses of nightshades to potentiate the psychedelics or did you really push the bar with them? Some detailed information on what exactly your methods and results have been surely would help these ideas along even just by bringing some more comparisons to work with to the table.

Have you had a chance to check out Thomas Ray's work on binding affinities by any chance? http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009019 Although he does list a high binding affinity for Mescaline and the 2-c substances with the 5-ht2b receptor. Interesingly, it also mentions M3, M4, and M5 action with MDMA.

I have seen that paper, though I'm usually not quick to trust it.... I've heard some negative things about it, including here on bluelight. One thing that stands out to me particularly is the fact that it lists D1 and D3 as being significant receptor sites for psilocin, despite the fact that it has consistently been shown to be non-dopaminergic in relevant concentrations in like every other test ever done on it. I do appreciate the contribution however, and for the sake of this discussion I will still run with your point....

I honestly wouldn't really be surprised if mescaline and the 2C-x family had 5-HT2B affinity based on the empathogenic feel of the drugs alone, it just goes against what I had read before. I am currently struggling to find the source of the information I had though; 5-HT2B information in general seems to be frustratingly sparse. If we assume for the sake of this discussion that there is some validity to that, it's important to remember that other factors may be contributing as well. One thing that comes to mind is how I was talking about the ratios before.... 2C-B at least, and I would say 2C-I too (but I don't have experience with any others or mescaline so I can't really compare), seem to have their empathogenic qualities reachable at doses where psychedelia is still quite weak. Judging from that alone, if they do work through 5-HT2B, I don't think it would be crazy to think that they're more selective for it than 5-HT2A, or at the very least that they have a higher efficacy for it. This I wouldn't actually find surprising at all, as I've read a paper in the past suggesting that 2C-B, 2C-C, 2C-D, and 2C-I all actually have very low efficacy at the 5-HT2A receptor. Low enough perhaps to maybe even have some anti-serotonergic properties there? But still enough to activate visuals I would guess, considering that that particular effect would always be greater than serotonin's own. Interestingly, I don't think applies to 2C-E. The DOx compounds are also definitely powerful psychedelics, and they act fairly non-selectively for all 5-HT2 receptors as far as I can tell. If the theory I stated before does apply, maybe this would put these compounds on that same scale, in the sense that the 2C-x family would be more similar to mushrooms in causing more empathogenic/deliriant qualities per psychedelia, and the DOx family would be more similar to DMT in causing the same amount leading to more hyperspatial effects. One thing I can definitely say for sure is that I've experienced entity contact on a very high dose of 2C-I, and I just assumed it was mostly a dopaminergic effect.... Maybe I just wasn't considering them on a wide enough scale?

Another thing to consider would be the contribution of other serotonin receptors to this effect, such as 5-HT1/5/6/7, like with how I was saying that theoretically the more similar the psychedelic is to serotonin the more likely it should be to mimic its anticholinergic effect in the nucleus accumbens in addition to releasing serotonin through 5-HT2B, which would of course give them a leg up over compounds that do the latter much more than the former. I do wonder though if 5-HT1A in particular may be playing a significant role by increasing more dopamine and oxytocin and inhibiting the activity of NMDA receptors. With that in mind I don't think it would be out of the question to suggest that activity at that receptor may add an extra layer of dissociative effects here that would allow the psychedelic/deliriant effects to become more pronounced at lower levels of their own activity. I think this fits in with the idea that, as far as the studies I can find have shown, DMT also has a higher ratio of its 5-HT1A to 5-HT2A effects than psilocin does, and the DOx family I believe binds to 5-HT1A as well while I'm not so sure the 2C-x family does, or at least if they do then I don't believe it's as strongly. Also, personally, just from the accounts I've heard of mescaline it wouldn't surprise if there was some of this deliriant quality going on at least at some dose, again I had assumed to to dopamine receptor activation, and maybe it is some other relationship like this that accounts for some of these discrepancies. Or maybe it just gets overlooked more often because people don't often push phenethylamines as far as they push tryptamines?

I know this wasn't the focal point of your original post, but I do think it's really important. This has been my experience as well and I definitely think it deserves more attention. With majority of my low to mid range Nightshade trips there have been definite "psychedelic" characteristics, especially when additional substances are taken to potentiate the visuals of the deliriants. If more people realized this, I think readers would notice a vast increase in the general enjoyability of the TR's on these substances. They're definitely misunderstood to say the least :)

But yeah, fantastic read...some great ideas in there! :)

I would certainly have to agree. That doesn't mean I don't think they needed to be treated with great care and that real consideration doesn't need to be taken in regards to their physical effects and so on and so forth... but there's a lot more to deliriants than people generally pay attention to, I think. Though, I'd be lying if I said I'm not hoping this thread will help convince me that I can get everything I liked from them just by using mushrooms or DMT, hehe.

And thanks so much, I'm glad you liked it! :D
 
Alright, I've been trying to recap and think of new angles for this, as well as throwing in some other possible mechanisms of action.... Following the idea that increased release of serotonin might induce delirium, possibly through that nucleus accumbens mechanism but who know for sure, I've been thinking about what all might factor into the dream-like hallucination generation of psychedelics. What I'm thinking about right now is that the major factors would be selectivity of serotonin receptor agonism, the specific ratio of 5-HT2A to 5-HT2B agonism, whether or not it also doubles as a serotonin releasing agent, and inhibition of MAO-A. I'll summarize what I'm thinking for each class of drugs here.

On one end you've got the only mildly psychedelic but rather strongly delirious compounds, the MDx family and its analogues. These all tend to be weak to low-moderate agonists of 5-HT2A and potent agonists of 5-HT2B, causing inhibition of the serotonin transporter, along with enhancing this effect through releasing agent properties. The resulting effects is very high levels of serotonin roaming around in your brain. However, as phenethylamines, most of them are not likely to have nearly as widespread of a serotonin receptor agonism as a tryptamine should. Along with some low-level psychedelic effects from 5-HT2A, this amounts to light patterns, tracers, maybe some distortions, and etc., along with well-structured hallucinations like those mentioned of seeing glasses on people's faces, or seeing tables or people on the dance floor, or other various things that are not actually there. The idea for this would basically be like it's pretty much just serotonin but with a little bit of psychedelic flavoring, which also brings out the non-psychedelic hallucinogenic effects of the serotonin itself.

Next up, there's the 2C-x family. These lack the releasing agent effects, but they are empathogenic. As discussed above, it is quite possible that they activate 5-HT2B. This still amounts to less serotonin release than the MDx family, and they're still lacking in the serotonin non-selectivity, but they do have a stronger effect on 5-HT2A receptors. I see this as sort of bridging the gap, so to speak, from the MDx compounds.... The delirious potential is a little less, but the psychedelic potential is a little more. What it would amount to with the previous comparison would be like being on a lower but more psychedelic dose of serotonin. I feel that this matches quite well with the fact that most 2C-x drugs are thought to be "lighter", psychedelic but still easier on the mind at regular doses. A notable exception would be 2C-E, but as I mentioned before, most of these compounds that have been tested (2C-B, 2C-C, 2C-D, 2C-I) seem to have low efficacy at 5-HT2A but still enough to cause psychedelic hallucinations, but this doesn't seem to be the case with 2C-E. For that reason it could be ranked a bit higher than the rest of these in terms of psychedelic potential, kind of just like the next step up. I believe that that's the perfect segue into this next group. The matter of low vs high efficacy at 5-HT2A could be what significantly separates those "easier" psychedelics from their somewhat more spiritual kin, such as mescaline, the DOx family, and the aforementioned 2C-E. These drugs have a similar empathogenic profile to what I've mentioned so far, but they have a more classically psychedelic state of mind and level of abstract hallucinations through which to express those effects.

After that there's the category that hasn't really been discussed here yet.... What really interests me is the 2C-T-x family, particularly 2C-T-7. It is known both for being an inhibitor MAO-A and for causing particularly vivid and powerful hallucinations for its class. In fact, many of the reports I've read with it definitely do have that psychotic/delirious feel, especially the higher dose ones. I don't think it should otherwise be that different from the other phenethylamine compounds mentioned, so if widespread serotonergic activity adds to the delirium of a psychedelic compound and 2C-T-7 is empathogenic, potentially suggesting 5-HT2B activity like with the others, then would it be crazy to suggest that inhibiting MAO-A and serotonin metabolism could lead to this strong potentiation of hallucinations? I certainly don't think so. I'll get back to this concept soon, but I'll leave it there for now.

Next up seems to be the only psychedelic that we know for sure lacks any 5-HT2B activity at regular doses, LSD. However, it makes up for this in its own way by being much more similar to the tryptamines than the phenethylamines in its widespread agonism of serotonin receptors. It's still not quite at their level, but it's more than the compounds I've mentioned so far. Intriguingly, LSD is known for being an extremely clearheaded psychedelic. Could this be why? It makes up for what it lacks in serotonin release with some serotonin agonism, but that would still put it on about the same stage as, say... something like mescaline or 2C-E. That sounds about right to me, from everything I've heard anyway.

Finally, we arrive at the tryptamines. Psilocin and DMT specifically are known to bind to 5-HT2B and 5-HT2A potently, in addition to most other serotonin receptors. The outcome of this, at least as far as I could see it, would be that their widespread serotonergic activity could reach levels, or push beyond levels, of the MDx compounds, creating levels of pure delirium, distinct from the classical psychedelic activity, that have yet to be matched by anything I mentioned unless high doses of those are taken. The difference is that they're also very powerful classical psychedelics in their own right, and as I've stated, I feel that this could be where the typical tryptamine breakthrough experiences come from. Another thing that interests me specifically that I haven't really mentioned here yet is AMT and 5-MeO-AMT... both of which are non-selective serotonin agonists, serotonin releasing agents, AND moderate MAO-A inhibitors. As far as I know they're both known for creating pretty vivid hallucinations as well, though they fall victim to the same problem with the MDx family, being that you can only push them so far. Does anyone here have much experience with them to contribute? What it really brings me to though is this, and you may have picked up on it by now.... Ayahuasca. It's a combination of DMT and MAO-A inhibitors, and they do other things too, but that's mainly what they're used for here. Sure, it's to activate DMT orally, but that doesn't mean it's not doing other things too right? I don't think you'll find many travelers out there who say that there's no difference between DMT with and without MAOIs. So if DMT is actually causing that serotonin release from 5-HT2B as well in addition to its own powerful psychedelia and non-selective serotonin agonism, is it not possible that the MAO-A inhibition of the harmalas is not only increasing the effect of the DMT but the serotonin its releasing as well, bringing users to the complete and extremely powerful dream landscape that this brew is known for?

I was a little rushed at the end there, I actually should have left home to get to an appointment already, so I apologize if it seems like I sped through something or skipped some stuff, but this is pretty much how I've been feeling right now. Does this jive well with everyone?
 
Wandering Girl said:
I'm glad you agree! It's nice to see another person experienced with deliriants here, it definitely helps to expand this theory. I'm quite interested in your experience with combinations of psychedelics and deliriants, actually. Were you only using small doses of nightshades to potentiate the psychedelics or did you really push the bar with them? Some detailed information on what exactly your methods and results have been surely would help these ideas along even just by bringing some more comparisons to work with to the table.

Awesome!! It's great to see another deliriant user here...lol besides the occasional datura horror story, I don't see too many serious deliriant users here on the boards. It's actually been a theory I've been contemplating for a while...that the whole phenomenon of "breakthrough" is in someway related to the mechanisms of the deliriant experience. Oh and yeah, Im almost always proportionate in my combination of Nightshades and psychedelics...a level 5 psychedelic dose would be accompanied by a level 5 deliriant dose and so on.

The methodology for deliriant use is always in the form of a combinative brew. On deliriants alone, the brew usually consists of: a Nightshade of choice (Belladonna, Datura Metel, or Henbane), Viburnum opulus, Opium, Citric Acid, and Strychnine. I'll also sometimes use the old Egyptian recipe of Mandrake, Opium, and Blue Lotus...with Viburnum opulus and Citric Acid added in again. On psychedelic plus deliriant combos, I'll usually leave out the Opium unless I feel the dose I'd be taking would be so high that'd I'd need the antagonistic belladonna/morphine relationship in order to avoid severe somatic side-effects. Dosages are dependent upon which Nightshade I use, and scopoletin appears to potentiate the visual effects of Nightshades while lessening any mental anticholinergic haze (others online have corroborated this as well)...so the dosage is adjusted accordingly.

The results are probably as expected...100% full and complete total immersion into the psychedelic realm. Infinitely more real than any breakthrough experience I've had on DMT or mushrooms alone. It no longer has the aura of a trip at all...I see these combinations more as tools to physically step into a different reality. A reality that's fully formed, completely interactive, tangible yet has an entirely different set of physics, and populated by entities seeming to posses as much of an independent conscious will as those in this reality. An actual literal step into the spirit realm.

Wandering Girl said:
I have seen that paper, though I'm usually not quick to trust it.... I've heard some negative things about it, including here on bluelight. One thing that stands out to me particularly is the fact that it lists D1 and D3 as being significant receptor sites for psilocin, despite the fact that it has consistently been shown to be non-dopaminergic in relevant concentrations in like every other test ever done on it.

I've read the thread on bluelight in which the topic title was the same as the paper title...the positive responses vastly outweighed the negatives. And most of the few complaints were dealt with inside the thread itself. Also, referring to D1 and D3, "every other test done on it" is not really saying much...as stated in the study Psilocybin-induced stimulus control in the rat, "Binding data for psilocybin and psilocin are limited and not directly comparable". I believe I know what you're mentioning though...most references are usually to a 1975 paper "The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states"...although I dont have access to their methodology to make a comment on it (I cant access the paper...lol, although I strangely just noticed that I know the professor and maybe could inquire for details). I do realize that the Thomas Ray work is controversial in that its trying to break new ground by stating that the qualitative diversity of psychedelic drugs couldn't be accounted for by action at a single receptor...but until I can see an updated and detailed listing of psilocin binding affinities (which I can't even see in the original paper), Im going to say the question is still open.

I wish I could comment more, as your middle two paragraphs are fantastic and full of great ideas...but without sources it's a bit tough to comment on. I really do like where you're headed with this though...I pretty much have the same general opinion, I just feel that something else might be the cause and not necessarily 5-ht2b. It's great stuff though, I really am loving it! :D

Wandering Girl said:
Though, I'd be lying if I said I'm not hoping this thread will help convince me that I can get everything I liked from them just by using mushrooms or DMT, hehe.

hahaha, yeah I hear ya! It certainly would be nice! Ive thought that might be possible at times as well...after experimenting with the deliriant and psychedelic combo for so long though, the mix does seem to take things to a new level that Ive never experienced on mushrooms or dmt alone. If you ever decide to give it a try I'd of course really really be interested in hearing how things go for you. But yeah, there definitely seems to be a delirium aspect to these particular substances...But after mixing with Nightshades I get the impression that there's still a lot more delirium and immersion to be had than just with the tryptamines themselves. But I guess that could even get deeper into phenomenology, ontology, etc...things like plant-spirit interactions could theoretically play a vital role in the experience in a way that can't be quantified or transferred between substances, receptors, etc. Oh man, it sure is a fascinating question though...it's awesome that you brought it up! :D
 
Last edited:
Lol I just wrote a response to the previous message without realizing you wrote another one....I'll try to check that one out too and get back to you. Again, great stuff though! :)
 
Viṣakaṇṭha;11947757 said:
Awesome!! It's great to see another deliriant user here...lol besides the occasional datura horror story, I don't see too many serious deliriant users here on the boards. It's actually been a theory I've been contemplating for a while...that the whole phenomenon of "breakthrough" is in someway related to the mechanisms of the deliriant experience. Oh and yeah, Im almost always proportionate in my combination of Nightshades and psychedelics...a level 5 psychedelic dose would be accompanied by a level 5 deliriant dose and so on.

...

The results are probably as expected...100% full and complete total immersion into the psychedelic realm. Infinitely more real than any breakthrough experience I've had on DMT or mushrooms alone. It no longer has the aura of a trip at all...I see these combinations more as tools to physically step into a different reality. A reality that's fully formed, completely interactive, tangible yet has an entirely different set of physics, and populated by entities seeming to posses as much of an independent conscious will as those in this reality. An actual literal step into the spirit realm.

I must say that I'm quite interested in your methodology, I'll be PMing you about that if you don't mind as to not derail this thread too far!

I'm fascinated by the way you describe these experiences. This is what I always assumed a psychedelic/deliriant combo would be like in full force, but I never got around to it back in the day. I used to fantasize about such a thing because I felt a mixture like that would be the only real way to push beyond what deliriants are already capable of on their own, as I certainly wouldn't just eat datura to my heart's content to trip harder and harder.... I can't help but wonder even more about this now after learning about the anticholinergic effects of serotonin in the nucleus accumbens, especially since that is a brain area that would just make a whole lot of sense to be the source of delirium. If it truly is how psychedelics are getting their breakthrough effects, that would be an incredible thought.... I can relate to how if I was on a psychedelic with physical side effects, such as a DOx or 25x-NBOMe, and I felt that I couldn't dose any higher without being in danger, I could still just smoke weed instead to enhance the trip. I feel that that would be a valid way to explore it further because endocannabinoid release is already a significant part of 5-HT2A receptor activation, so it would be like bringing out more of a quality that the trip already had without having to take further risk, in addition to adding a new flavoring to it.... If the theory about serotonin is correct, I could see it as doing exactly the same with a safe psychedelic to a dose of a deliriant where I would not feel safe in pushing myself further. Again, it's fascinating... though of course, still all hypothetical at this point. Even aside from the neurochemistry aspect though, I find just the thought itself of combining the two forms of delirium to be very stimulating. Thank you very much for the response! :)

I've read the thread on bluelight in which the topic title was the same as the paper title...the positive responses vastly outweighed the negatives. And most of the few complaints were dealt with inside the thread itself. Also, referring to D1 and D3, "every other test done on it" is not really saying much...as stated in the study Psilocybin-induced stimulus control in the rat, "Binding data for psilocybin and psilocin are limited and not directly comparable". I believe I know what you're mentioning though...most references are usually to a 1975 paper "The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states"...although I dont have access to their methodology to make a comment on it (I cant access the paper...lol, although I strangely just noticed that I know the professor and maybe could inquire for details). I do realize that the Thomas Ray work is controversial in that its trying to break new ground by stating that the qualitative diversity of psychedelic drugs couldn't be accounted for by action at a single receptor...but until I can see an updated and detailed listing of psilocin binding affinities (which I can't even see in the original paper), Im going to say the question is still open.

I wish I could comment more, as your middle two paragraphs are fantastic and full of great ideas...but without sources it's a bit tough to comment on. I really do like where you're headed with this though...I pretty much have the same general opinion, I just feel that something else might be the cause and not necessarily 5-ht2b. It's great stuff though, I really am loving it! :D

I get what you're saying, but I still am cautious of it. And that 1975 paper factored into it, but it wasn't the only one. I've definitely seen different studies on Erowid as well which tested multiple psychedelic compounds for potential dopaminergic activity and found that psilocin had literally none. Again, though, this would be with rats. It's difficult to say what's going on in us for sure.

Yeah, I know I could find the sources again if I wanted to, I'm just usually not feeling up to it enough to grab them all haha.... I'm mainly just trying to get ideas in peoples' heads anyway, as it's not like I'm intending to prove anything just by connecting these concepts. I'm glad you like it though! About 5-HT2B, it's quite possible that even the theories discussed in this thread would point to other serotonin receptors instead, given that 5-HT2B could simply just be a source for more serotonin release which causes the delirium through a different mechanism. I don't think that would discount 5-HT2B as being a cause of it though... just like I wouldn't discount CB1 for being the hallucinogenic receptor for cannabinoids even if the hallucinations themselves are caused by dopamine release, for example. There's certainly going to be a very large and beautifully convoluted picture no matter how you look at it when it comes to the brain.

hahaha, yeah I hear ya! It certainly would be nice! Ive thought that might be possible at times as well...after experimenting with the deliriant and psychedelic combo for so long though, the mix does seem to take things to a new level that Ive never experienced on mushrooms or dmt alone. If you ever decide to give it a try I'd of course really really be interested in hearing how things go for you. But yeah, there definitely seems to be a delirium aspect to these particular substances...But after mixing with Nightshades I get the impression that there's still a lot more delirium and immersion to be had than just with the tryptamines themselves. But I guess that could even get deeper into phenomenology, ontology, etc...things like plant-spirit interactions could theoretically play a vital role in the experience in a way that can't be quantified or transferred between substances, receptors, etc. Oh man, it sure is a fascinating question though...it's awesome that you brought it up! :D

If that day ever comes it will likely be far in the future, as I'm not even really actively using psychedelics alone at the moment, but I will certainly let you know if I ever do! I get you though. If that anticholinergic serotonin thing turns out to be true, it would make perfect sense to me as well.... Deliriants would just be like skipping the rest of the psychedelic mumbo-jumbo and getting straight to the bulk of things, which to me seems like it could take you further out without muddling things up as much. Either way, I've always found deliriants to be the most stunning of the hallucinogens. I'm very happy that you chose to read and respond to this thread, and that you enjoy it. :) Thanks again for all the information!
 
Please, no need to 'memberate' in that way--his post was within the scope of the discussion as the de facto topic expanded.
...



An interesting idea. Think of the states toward the end of high-dose entactogen use, eg mistaking people's face, hallucinating nonexistent glasses, etc.

ebola

I disagree. Discussing all of the various functions (especially purely physical ones) of the 5-ht2b receptor is not within the scope of discussing its effects which may contribute to psychedelia. Just my opinion, however. I think saying that that was within the bounds of discussion opens the discussion up to ranting about unrelated stuff like physical problems associated with 5-ht2b receptors.

5-ht2b and 5-ht2c are always talked about very negatively, but I'm starting to think they may contribute to the psychedelia. Are there any psychedelics which only weakly affect 5-ht2a compared to 2b or 2c (or both). Or any that show high IA (I think Im using the right acronym) for 2b or 2c.
 
Thank you, bloodshed344. I'm glad that there are others who feel this way as well. The MDx family and related chemicals (such as 5- and 6-APB) would be examples of psychedelics that bind weakly to 5-HT2A compared to 5-HT2B, and I discussed why I think they're great examples already. Looking at the anecdotal evidence, they do seem to provide a much higher level of delirium compared to "classical" 5-HT2A effects like sensory distortions and ego loss compared to other psychedelics. By IA are you referring to the imidazoline receptor subtype? If so I'm not really sure about that one, but I would like to learn more.

I have more ideas that I've been working on about all this but I'm still trying to pull them together right now, so I may be posting them later tonight. We'll see how it turns out!
 
Thank you, bloodshed344. I'm glad that there are others who feel this way as well. The MDx family and related chemicals (such as 5- and 6-APB) would be examples of psychedelics that bind weakly to 5-HT2A compared to 5-HT2B, and I discussed why I think they're great examples already. Looking at the anecdotal evidence, they do seem to provide a much higher level of delirium compared to "classical" 5-HT2A effects like sensory distortions and ego loss compared to other psychedelics. By IA are you referring to the imidazoline receptor subtype? If so I'm not really sure about that one, but I would like to learn more.

I have more ideas that I've been working on about all this but I'm still trying to pull them together right now, so I may be posting them later tonight. We'll see how it turns out!

You can't discount the 5-HT release caused by that class of compounds though, it's hard to deny that factor in their subjective effects.

Which I guess brings us back to the question of whether 5-HT2B agonism is sufficient to cause 5-HT release. We know it's necessary for 5-HT release because if you block 5-HT2B you block 5-HT release as well.


Are there any strong 5-HT2B agonists that DON'T cause 5-HT release? If every 5-HT2B agonist in existence is also a 5-HT releaser it would be hard to argue that 5-HT2B agonism isn't sufficient.
 
Wandering Girl said:
I can relate to how if I was on a psychedelic with physical side effects, such as a DOx or 25x-NBOMe, and I felt that I couldn't dose any higher without being in danger, I could still just smoke weed instead to enhance the trip. I feel that that would be a valid way to explore it further because endocannabinoid release is already a significant part of 5-HT2A receptor activation, so it would be like bringing out more of a quality that the trip already had without having to take further risk, in addition to adding a new flavoring to it....

Well, yes, but downstream AA release probably differs a lot in effect from widespread exogenous cb1 agonism.

The matter of low vs high efficacy at 5-HT2A could be what significantly separates those "easier" psychedelics from their somewhat more spiritual kin, such as mescaline, the DOx family, and the aforementioned 2C-E.

I think that this only partially pans out. Mescaline is still a partial agonist at these receptors, but it has non-negligible affinity for 5ht1a. 2CE also seems a bit broader spectrum in 5ht affinities, but it lacks significant affinity for 5ht1a and tends to be a partial agonist as well. And the the nBOMe compounds are widely regarded as 'shallow' but are full agonists at 5ht2a.

After that there's the category that hasn't really been discussed here yet.... What really interests me is the 2C-T-x family, particularly 2C-T-7. It is known both for being an inhibitor MAO-A and for causing particularly vivid and powerful hallucinations for its class.

Well, it turned out that mao-inhibition for 2ct-series compounds ended up being quite mild, so broader spectrum agonism appears more responsible for observed distinctions in effects.


Next up seems to be the only psychedelic that we know for sure lacks any 5-HT2B activity at regular doses, LSD.

LSD actually binds with high affinity at 5ht2b, eclipsing its activity at 5ht2a.

LSD is known for being an extremely clearheaded psychedelic.

Clearer headed than most phenethylamine psychedelics though?

AMT and 5-MeO-AMT... both of which are non-selective serotonin agonists, serotonin releasing agents, AND moderate MAO-A inhibitors.

I would deem them likely weak inhibitors of maoa.
...
The difficulty in adjudicating your hypothesis is that nearly all recreational psychedelics exert significant agonism at 5ht2b, so we lack much of a comparison case, outside of 5meodmt, which while mystical and befuddling, lacks classical hallucinatory delirium. I still think you may be onto something. Inroads could be made by comparing psychedelic action with concurrent administration of ACh agonists and without, but this can't really discriminate suppression of 5ht2b mediated anti-cholinergic activity from additive effects from activity at 5ht2b and ACh agonism.

Still, I find your hypothesis intriguing and potentially viable.

Here is a REALLY handy reference for you:
...
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009019

bloodshed said:
I think saying that that was within the bounds of discussion opens the discussion up to ranting about unrelated stuff like physical problems associated with 5-ht2b receptors.

And yet the only discussion about 5ht2b mediated toxicity that occurred was meta-discussion about whether tweex should have made that post. "Be the change" and all. ;)

ebola
 
You can't discount the 5-HT release caused by that class of compounds though, it's hard to deny that factor in their subjective effects.

Which I guess brings us back to the question of whether 5-HT2B agonism is sufficient to cause 5-HT release. We know it's necessary for 5-HT release because if you block 5-HT2B you block 5-HT release as well.


Are there any strong 5-HT2B agonists that DON'T cause 5-HT release? If every 5-HT2B agonist in existence is also a 5-HT releaser it would be hard to argue that 5-HT2B agonism isn't sufficient.

This study, though unfortunately relating to pulmonary function (like I said, 5-HT2B studies don't seem to be too common...), would seem to suggest that at least in some areas of the body 5-HT2B is sufficient to release serotonin on its own: Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice.

A correlation between high plasma serotonin levels and total pulmonary resistance was reported in more than 80% of pulmonary hypertensive patients. When submitted to chronic hypoxia (10% O(2) for more than 3 weeks), wild-type mice develop lung vascular remodeling and pulmonary hypertension. We previously reported that, in contrast, the development of these hypoxia-dependent alterations is totally abolished in mice with permanent (genetic) or transient (pharmacologic) inactivation of the serotonin 5-hydroxytryptamine (5-HT)(2B) receptor. In the present study, we asked whether 5-HT(2B) receptors could be involved in the control of plasma serotonin levels. Further investigating the chronic hypoxic mouse model of pulmonary hypertension, we first show that in wild-type mice, plasma serotonin levels and 5-HT(2B) receptors expression were significantly increased after chronic exposure to hypoxia. This increase appeared before significant changes in remodeling factors could be detected and persisted when the pathology was established. Conversely, in mice with either genetically or pharmacologically inactive 5-HT(2B) receptors, plasma serotonin levels were not modified by chronic hypoxia. We then confirmed that 5-HT(2B) receptors can control plasma serotonin levels by providing in vivo evidence that an acute agonist stimulation of 5-HT(2B) receptor triggers a transient increase in plasma serotonin that is serotonin transporter dependent and blocked by 5-HT(2B) receptor-selective antagonist or genetic ablation. Our data support the notion that a 5-HT(2B) receptor-dependent regulation of serotonin uptake is implicated in the control of plasma serotonin levels.

I would love to see the full article to be sure, but if I'm reading that correctly then it seems that deactivating 5-HT2B even without a serotonin releasing agent present still reduces serotonin levels, and though I would very much like to know what 5-HT2B agonist they used in this before saying anything for sure, I can't imagine that they would have used anything currently known to stimulate serotonin release for this test. It wouldn't make a whole lot of sense. If only I could find a study where they specifically tested for this in the brain....

Well, yes, but downstream AA release probably differs a lot in effect from widespread exogenous cb1 agonism.

That's why I put the "in addition to adding a new flavor to it". When you can't push further with the method you've been using you make due with what you have, right?

I think that this only partially pans out. Mescaline is still a partial agonist at these receptors, but it has non-negligible affinity for 5ht1a. 2CE also seems a bit broader spectrum in 5ht affinities, but it lacks significant affinity for 5ht1a and tends to be a partial agonist as well. And the the nBOMe compounds are widely regarded as 'shallow' but are full agonists at 5ht2a.

Well, most psychedelics are partial agonists at 5-HT2A, but when I refer to 2C-B/C/D/I according to the study I read I'm talking about in the range of something like 4-12% efficacy depending on the drug. I don't believe that either mescaline or 2C-E are that low. As I mentioned though, I do believe that all of the other serotonin receptors are very important to consider as well....

Also, some people may consider the 25x-NBOMe family shallow, but I wasn't. I was ranking them in the same line as mescaline/2C-E/DOx.

Well, it turned out that mao-inhibition for 2ct-series compounds ended up being quite mild, so broader spectrum agonism appears more responsible for observed distinctions in effects.

Even at very high doses, though? The main example I was thinking of for 2C-T-7 involved taking something reckless like 80 mg. I've taken very high doses of 2C-I before and they never reached that same level of intensity.

LSD actually binds with high affinity at 5ht2b, eclipsing its activity at 5ht2a.

Maybe I'm wrong, but doesn't that study you linked actually put 5-HT2A as its stronger affinity? And why then do some older studies rank its 5-HT2B agonism so much lower? (I hope you realize I'm not just trying to question everything you say here either, I'm just genuinely interested in why such large differences in data would appear.)

Clearer headed than most phenethylamine psychedelics though?

I never said that it was, I put it in the same like as mescaline and 2C-E. When I said that what I actually had in mind was how clearheaded it was compared to something like mushrooms despite having much in common with tryptamines.

I would deem them likely weak inhibitors of maoa.

I'm pretty sure you mean the same thing I did honestly, just on a different scale. They definitely do have MAO inhibitory properties that can appear at recreational doses, even if those doses are considered high.

The difficulty in adjudicating your hypothesis is that nearly all recreational psychedelics exert significant agonism at 5ht2b, so we lack much of a comparison case, outside of 5meodmt, which while mystical and befuddling, lacks classical hallucinatory delirium. I still think you may be onto something. Inroads could be made by comparing psychedelic action with concurrent administration of ACh agonists and without, but this can't really discriminate suppression of 5ht2b mediated anti-cholinergic activity from additive effects from activity at 5ht2b and ACh agonism.

Still, I find your hypothesis intriguing and potentially viable.

Once again, I'd just like to say that I hope you do know that I'm just trying to branch off of what you're saying to keep the discussion going here.... I worry a lot about not coming off the right way through text. I really do appreciate the support and your willingness to discuss this. :)

That's really interesting about 5-MeO-DMT... definitely gives me something else to consider. You say that that's the only case, but I disagree. That would be one side, with very low 5-HT2B affinity, but the MDx family and analogues are on the other side and they can have very strong delirium. In fact, I would take it a step further and point out that by the paper you linked it seems clear to me that the general trend is for tryptamines to be more selective for 5-HT2B than 5-HT2A whereas phenethylamines and amphetamines seem to be fairly consistent, which follows very well with their general potential to cause hyperspatial effects. The exceptions to this, aside from the aforementioned 5-MeO-DMT and MDx chemicals, would be DOM, also generally thought of as a very powerful and vivid psychedelic in full doses, 2C-B-Fly, which by all reports I've ever read actually does have some extremely realistic closed-eye visuals, and mescaline, which has already had a good case made for it.

I want it to be clear that I'm not married to the idea of 5-HT2B being the source of these effects, and that's why I'm willing to constantly rework the concept with new opinions and information that comes in, but by all sources that I can see I feel that it's a very valid possibility. I actually feel even better about it now after having looked more closely at that paper.

About the anticholinergic theory, I also think it's important to consider something else.... It's a cool idea and I think it would be really neat if it all tied together, but it's still just one possible answer I pulled out. The actual focus should still be on the question "How does serotonin syndrome cause hallucinations?" I find that the fact that serotonin isn't psychedelic considering this to basically be proof that there are more hallucinogenic possibilities that arise from mimicking serotonin's structure than simply the 5-HT2A psychedelia that we all know. However, we still know so little about it, as far as I can tell.... Perhaps the smarter thing to do when paying attention to how closely it mimics anticholinergic delirium is not to ask "Are some serotonin receptors anticholinergic?" but "How do anticholinergics cause hallucinations?" Yes, they block muscarinic acetylcholine receptors... but what's the next step from there? And what part of the brain are they thought to generate the core of their hallucinogenic effects from?
 
Last edited:
Top